Ligand · 8OU
8OU · 4-[(1-methylindazol-5-yl)amino]-2-(4-oxidanylpiperidin-1-yl)-8H-pyrido[4,3-d]pyrimidin-5-one
8OU, 4-[(1-methylindazol-5-yl)amino]-2-(4-oxidanylpiperidin-1-yl)-8H-pyrido[4,3-d]pyrimidin-5-one (C20 H21 N7 O2, 391.4 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its residues…
- Component
- 8OU
- Formula
- C20 H21 N7 O2
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
8OU in 1 structure; the first of them:
- 5Y5U · Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor · 8OU A701 · binds LEU377, GLY378, SER379, VAL385, ALA400, VAL433, MET448, GLU449 and 7 more
Residues it binds most
GLY 2, LEU 2, ALA 2, GLU 2, MET 2, VAL 2, PRO 2, SER 2, ARG 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.